These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1902420

  • 1. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
    Nakamura Y, Yoshimura Y, Yamada H, Ubukata Y, Ando M, Suzuki M.
    Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
    Nakamura Y, Yoshimura Y, Yamada H, Maruyama K, Nanno T, Ubukata Y, Ando M, Takahashi K, Suzuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1620-6. PubMed ID: 2126024
    [Abstract] [Full Text] [Related]

  • 3. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
    Healy DL, Lawson SR, Abbott M, Baird DT, Fraser HM.
    J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
    [Abstract] [Full Text] [Related]

  • 4. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
    Watanabe Y, Nakamura G, Matsuguchi H, Nozaki M, Sano M, Nakano H.
    Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
    [Abstract] [Full Text] [Related]

  • 6. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V, Marquez J, Schally AV, Comaru-Schally AM, Leal G, Zacharias S, Gomez-Lira C.
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata.
    Franssen AM, Willemsen WN, Corbey RS, Doesburg WH, van 't Veen AJ, Rolland R.
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul 25; 40(3):221-8. PubMed ID: 1908799
    [Abstract] [Full Text] [Related]

  • 8. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
    Nakamura Y, Yoshimura Y.
    Clin Obstet Gynecol; 1993 Sep 25; 36(3):660-7. PubMed ID: 8403612
    [No Abstract] [Full Text] [Related]

  • 9. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1986 Dec 25; 63(6):1379-85. PubMed ID: 2946711
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun 25; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 11. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):1034-8. PubMed ID: 3927734
    [Abstract] [Full Text] [Related]

  • 12. Differential reduction in the volume of leiomyoma and uterus during buserelin treatment.
    Puzigaća Z, Prelević GM, Sretenović Z.
    Gynecol Endocrinol; 1994 Mar 15; 8(1):39-43. PubMed ID: 8059616
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
    Letterie GS, Coddington CC, Winkel CA, Shawker TH, Loriaux DL, Collins RL.
    Fertil Steril; 1989 Jun 15; 51(6):951-6. PubMed ID: 2498132
    [Abstract] [Full Text] [Related]

  • 14. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I.
    Fertil Steril; 1987 Oct 15; 48(4):560-4. PubMed ID: 3115833
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.
    Lemay A, Metha AE, Tolis G, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1983 May 15; 39(5):668-73. PubMed ID: 6404661
    [Abstract] [Full Text] [Related]

  • 16. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 17. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD.
    Fertil Steril; 1996 Jul 01; 66(1):101-4. PubMed ID: 8752618
    [Abstract] [Full Text] [Related]

  • 18. Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Fertil Steril; 1984 Oct 01; 42(4):644-6. PubMed ID: 6436065
    [No Abstract] [Full Text] [Related]

  • 19. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR, Marshburn PB, Weatherall PT, Bradshaw KD, Breslau NA, Byrd W, Roark M, Steinkampf MP.
    J Clin Endocrinol Metab; 1993 May 01; 76(5):1217-23. PubMed ID: 8496313
    [Abstract] [Full Text] [Related]

  • 20. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor.
    Shozu M, Murakami K, Segawa T, Kasai T, Inoue M.
    Fertil Steril; 2003 Mar 01; 79(3):628-31. PubMed ID: 12620453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.